PAUL CORN to RANK Ligand
This is a "connection" page, showing publications PAUL CORN has written about RANK Ligand.
Connection Strength
0.117
-
Novel therapies for metastatic castrate-resistant prostate cancer. J Natl Cancer Inst. 2011 Nov 16; 103(22):1665-75.
Score: 0.096
-
Dasatinib inhibits both osteoclast activation and prostate cancer PC-3-cell-induced osteoclast formation. Cancer Biol Ther. 2009 Nov; 8(22):2153-9.
Score: 0.021